ArticleThe international journal of cardiovascular imaging2026
Accuracy and prognostic value of arm-exercise stress echocardiography for coronary disease.
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exercise stress echocardiography (ExSEC) is a well-established modality for evaluating coronary artery disease (CAD). In individuals with lower limb impairments, arm exercise stress echocardiography (Arm-ExSEC) represents a potential alternative; however, data supporting its predictive value are lacking. This study aimed to assess the diagnostic and prognostic utility of Arm-ExSEC for CAD detection in this population. A retrospective analysis was conducted on 68 patients with lower limb disabilities (47% male; mean age 67.6 ± 10.6 years) to evaluate the ability of Arm-ExSEC to detect CAD, as confirmed by coronary angiography, and to predict a composite outcome of myocardial infarction and cardiac mortality at 1-year follow-up. Arm-ExSEC demonstrated a sensitivity of 72%, specificity of 80%, and an overall accuracy of 76% for detecting CAD. Survival analysis showed a higher incidence of the primary outcome among patients with positive Arm-ExSEC compared to those with negative results (log-rank test, p = 0.007). In multivariable Cox-regression analysis adjusted for age and sex, a positive Arm-ExSEC remained independently associated with the primary outcome (hazard ratio [95% CI], 10.50 [1.20-91.93]; p = 0.034). These findings suggest that Arm-ExSEC may serve as a valuable modality for both the diagnostic and prognostic assessment of CAD in patients with lower limb impairments.
Indexed as
Identifiers
41233701What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.